Connection | Profiles RNS

Search Result Details

Back to Search Results

This page shows the details of why an item matched the keywords from your search.

Search Results

Bargonetti, Jill

One or more keywords matched the following items that are connected to Bargonetti, Jill

Item Type	Name
Academic Article	Dietary downregulation of mutant p53 levels via glucose restriction: mechanisms and implications for tumor therapy.
Academic Article	Mutant p53 disrupts mammary tissue architecture via the mevalonate pathway.
Academic Article	Site-specific binding of wild-type p53 to cellular DNA is inhibited by SV40 T antigen and mutant p53.
Academic Article	Mutant p53 cooperates with the SWI/SNF chromatin remodeling complex to regulate VEGFR2 in breast cancer cells.
Academic Article	Hot Spot Mutation in TP53 (R248Q) Causes Oncogenic Gain-of-Function Phenotypes in a Breast Cancer Cell Line Derived from an African American patient.
Academic Article	DNA-binding properties of the p53 tumor suppressor protein.
Academic Article	MDM2, MDM2-C, and mutant p53 expression influence breast cancer survival in a multiethnic population.
Academic Article	Measurement of gene expression by translational coupling: effect of copy mutations on pT181 initiator synthesis.
Academic Article	A proteolytic fragment from the central region of p53 has marked sequence-specific DNA-binding activity when generated from wild-type but not from oncogenic mutant p53 protein.
Academic Article	Staphylococcus aureus chromosomal mutations that decrease efficiency of Rep utilization in replication of pT181 and related plasmids.
Academic Article	Context-dependent roles of MDMX (MDM4) and MDM2 in breast cancer proliferation and circulating tumor cells.
Academic Article	Gain-of-Function Mutant p53 R273H Interacts with Replicating DNA and PARP1 in Breast Cancer.
Academic Article	Gain-of-function mutant p53: history and speculation.
Academic Article	Wild-type p53 mediates positive regulation of gene expression through a specific DNA sequence element.
Academic Article	A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans.
Concept	Mutation
Academic Article	Targeting Triple Negative Breast Cancer with a Nucleus-Directed p53 Tetramerization Domain Peptide.
Academic Article	The C-terminus of Gain-of-Function Mutant p53 R273H Is Required for Association with PARP1 and Poly-ADP-Ribose.
Academic Article	Patient-derived tumor organoids with p53 mutations, and not wild-type p53, are sensitive to synergistic combination PARP inhibitor treatment.
Academic Article	Patient-derived tumor organoids with p53 mutations, and not wild-type p53, are sensitive to synergistic combination PARP inhibitor treatment.

Search Criteria

Mutation

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support